• No results found

A Study of Post Transplant Pulmonary Infections.

N/A
N/A
Protected

Academic year: 2022

Share "A Study of Post Transplant Pulmonary Infections."

Copied!
82
0
0

Loading.... (view fulltext now)

Full text

(1)

!""#

(2)

! ! "

#

! $

%

#

(3)

&

' ($ )

' * # # !

#!# $ ++,

'

# !#- #.# ! "

' # !#- #.# ! " '

#

$ % & ' (

! ! /

- # -

" % 0++++&

(

! ! "

" % 0++ ++&#

(4)

1

! " #

# $

# ! !

&# . 2

1# . &1

2# 2

0# " ,+

,# 3 .

4# ! "

(5)

2

# '

# '

&# '

1# '

2# '

5 67% "' " 8

6. ' 3

#

(6)

0 A RETROSPECTIVE STUDY

" 9 +++

++0

#

# : ; +++ ; &

# $ 7

&# $ "' " # '

#

# 3 6 % 8 #

# ! #

&# $ #

1# : #

(7)

, '

#

# <

# 0

&# ,

1# ;

$ % # % ! &

# $ = 6$.'8

# 6 ' !8

&# " 6"!> 8 1# " 6 "> 8

2# ?

'

#

(8)

4

' 7% "'

#

' 3 $?

# -

# $:3

&# @A

1# 3

2# !

0# :

'

> B " % 5 : *

' ) 3 ' #

(9)

C INTRODUCTION

=

# '

=

#

5

# '

D%

# '

6 8

(10)

+

# '

6 8 &#

E

# EPIDEMIOLOGICAL EXPOSURE

E

#

# "

! )

1#

&#

B# F

% 2#)

# '

#

(11)

THE NET STATE OF IMMUNOSUPPRESSION '

F

# D%

5 #

# G D%

$

&#

1#

2#

0# ! D%

• G

• !

• $

(12)

,# D%

• "

• E %

• 3 "

• #

' *

#

$

5 5

# INCIDENCE

' %

# B

(13)

&

# "

=

#

'

#

C4+ & H

F ,H 4,H

0# 3

42H

C2H 4+H C+H 2

,#

# '

%

F 5

(14)

1

#

=

# $

# $

4

# "

#

#

TIME TABLE FOR INFECTION AFTER TRANSPLANTATION2 THIS IS ORGANISED INTO THREE SEGMENTS:-

# '

# A

&# !

(15)

2

' % ! $ $ % &

'

# .

#$

# G

=

#

=

%

C#"

# $

#

! C+

#

(16)

0

# '

B

%

# $

INFECTIONS ONE TO SIX MONTHS AFTER TRANSPLANTATION

$

#

# '

6 "!> E3> 3 >

"> > 8 #

'

$ ?

B #

(17)

,

INFECTION MORE THAN SIX MONTHS AFTER TRANSPLANTATION

)

% #

! 4+H

%

# ' I

# A

6 # #

8

2 +

=

#

'

?

"

$ # ? % B

(18)

4

#

A 2+H &+H

2H # 2H

# PULMONARY INFECTION

%

#

#E

# '

5 =

&#

.

#

# 3

(19)

C

#

' %

# '

' 6 #

8 6!

? 8 6

"!> 8 B 6 8

6 ) 8# '

#

(20)

+

PULMONARY INFILTRATES IN THE RENAL TRANSPLANT PATIENT1

' % ! ( $

3

)

- %

?

! :

$

"

!

"

>

6

" 8

) '

"

'

% # 3

+H # A

(21)

5

1#

# .

4+H

# 3

#

$

# $

%

#

%

#

%

5

# .

(22)

,# '

#

#

. 1+H 6

8

5 # " #

"!>

# $ H

# ' "!>

# B

%

) #

) 5

# 5

(23)

&

%

4#

' 5

1

2 I 2+

# !

#

# '

+#2 H

G )$1 1H E &#2 H ) $ #

2H +H 1#

!

'% # .

6 # # 8

% # A

2H 0

# #

(24)

1

C

5

+#

$ ! B

5 #& #' B

# A

#

# CLINICAL PICTURE

'

# '

# '

#

(25)

2

!

% #

) # $

A

0

# 3

%

# ?

# -

$ #

J : E 4#

#

" #

%

(26)

0

#

F

#

=

# )

6"'8 #

#

#

"

#

(27)

,

% #

APPROACH TO INVESTIGATION AND MANAGEMENT '

# '

#

# E

) B

6

8#

# ' 5

# "

# "'

(28)

4

% #

6 8 6 8

5 #

# $ 6 <14 8

"' # J

6

% 8

# '

) ? # A

#

# :

# $

(29)

C

"' #

# ) B

# E

$

6 8

#

# %

#

#

$

"'

# )

,2H 1 2# J

(30)

&+

5 5

% %

% % 6 B % %

8 % $

&#

' % %

"'

B 6

8 #

- "'

# '

% &% B

F B

%

0#

:

#

A %

% #

(31)

&

'

,#

'

# # % B

2 + K K

,2 ++ K K B

#

++ 2+ K

& 2 K # 6

2%&+ K 8

& 2+H

#

%

B 14+ C

% #

. 6; 4+H 8

# % B

6 # 1 K K

(32)

&

8 4# "

&++ C B #

$

+# ?

#

B # : B

6 ++% 2+

K 8F

# '

% 6 # #

8

6 # # F8#

B B

6

8 # $

B

(33)

&&

1 # E

#

. 6 <4 0+

8 6&+%1+H 8#

E 5

# )

# !

# FOCAL / SEGMENTAL INFILTRATES

)! ' %

• "

• J

# ! &

• ) - ) K

• 3 "

• ?:'

• ? :$

• ? :$ 6 8

(34)

&1

! *+ $ ! ' %

• " $ "

# ! &

• ' 3 3

DIFFUSE INFILTRATES

)! ' %

• " %

# ! &

• ) ?

• $

• - )

! *+ $ ! ' %

• " "!> K.)>

(35)

&2

# ! &

• $

• -

• " "!> .)>

CHARACTERISTIC PATTERNS OF PULMONARY INFILTRATES '

# :

6$. )8 " :#

" # :

$ "

# ! ?

$ '3 # .

"$ ? *

#

(36)

&0

? ?

)# # # !

$

"

# "

#

" # $

6 # " : " 6 # "!> 8#

'

" :# "

# "

$ B

@# )# #

'

(37)

&,

#

$%

" :

# $ $%

$ "

#

6 # # "!> B

L.)> " 8

" $ % ! + + ,

$ ? " :

"

?

" :

3

" :

@ )

) K"

$

"

.)>

"!>

"

$

'3K!$

$

"

"

$

$ '3K!$

(38)

&4

' # . 6 8 M 0,

' M 01 6 &#C,H 8

) , 2+ #! % & N 4#4

-

! 1CK01 6,0#20 H 8

: 2K01 6 &#1&H 8

+ ! % &

fever cough

expectoration

hemoptysis

dyspnoea

chest pain

(39)

&C

+ ! ' ! ! . / 0 12 3

# : 11 04#,2

# &C 0+#C&

&# E C 12#&

1# 2 ,#4

2# E 4#,2

0# " #20

BASIC DISEASE

CKD ( Unknown aetiology)

CGN FSGS

IgA nephropathy Alport syndrome Aortoarteritis CIN

DONORS

3

# : 0 C2#&H

# ) & 1#04H

(40)

1+

! ' ! ! . /0

12 3

# "@ 6G 8

1& 0,# 4H

# "- + 2#0 H

&# :)- ) & 1#04H

1# $ &# H

2# $ #20H

0# $ #20H

,# " #20H

4# #20H

C# . #20H

+# > #20H

IMMUNOSUPPRESSION

conventional triple

' 3

# "

6$B O

8

2 &#1&H

# ' 6" $O $B O 8 1C ,0#20H

(41)

1

GRAFT FUNCTION DURING THE INFECTION

0 10 20 30 40 50 60

base line during infection

normal impaired

4 % % ! '

3 2C 6C # 4H 8 2 6,#4 H 8

&0 620# 2H 8 , 61 # 4H 8

(42)

1 TIME AT WHICH THE INFECTION OCCURRED

0 2 4 6 10 8 12 14 16 18 20

<1 m on th

1 - 6m on th s

7m on th s t o 1 Y r

II y ea r

III ye ar

IV ye ar

V ye ar

VI ye ar

VI I y ea r

Number

(43)

1&

"

.3/ ( # #

@ 2 622#22H 8

"

6 # H 8

6 # H 8

< C 6 1#+0H 8

G 6 # H 8

" .3/ ( # #

' ,6&4#4H 8

2 6 ,#,,H 8 2 6 ,#,,H 8

@ & 6 0#00H 8

$ !

6 # H 8

$ 62#2H 8

E 62#2H 8

) 62#2H 8

" 62#2H 8

I 0 4 6 4# H 8

G A & 6 0#00H 8

" .3/ ( # #

' 61+H 8

@ 6 +H 8

)# 6 +H 8

" 6 +H 8

6 +H 8

0 I 2 6,#4 H 8

G A 6 +H 8

(44)

11

" .3/ ( # #

' 1 6 2H 8

@ & 6 4#,2H 8 6 #2H 8

! 6 #2H 8

" 6 #2H 8

6 #2H 8

% 0 6 2H 8

G A & 6 4#,2H 8

" .3/ ( # #

' , 61&#,2H 8

@ 2 6& # 2H 8 1 6 2H 8 6 #2H 8

" 6 #2H 8

$

60# 2H 8

E# " 60#2H 8

) 60# 2H 8

; 0 6 2H 8

) 60# 2H 8

RISK FACTOR ANALYSIS FOR THE ENTIRE COHORT

! ' ! ! 3

? &2 21#04H

$.' 0 1+#0&H

"!> & +#& H

' ! 4#,2H

"> 4 #2H

(45)

12

SENSITIVITY OF SPUTUM STAIN VS. CULTURE

+ *

2 6 1#1&H 8

+ 6 2#0 H 8 1C

6,0#20H 8

21 641#&,H 8 SENSITIVITY OF SPUTUM VS. BAL ANALYSIS

)5

&K01 6&2#C&H 8

4K 4 6 ++H 8 1

601#+0H 8

+K 4 6+H 8 SENSITIVITY OF IMAGING STUDIES

6 !$ + !$

2 K01 6,C#0CH 8

1K C 64 #,0H 8

&K01 6 +#& H 8

2K C 6 ,# 1H 8

(46)

10

NON TUBERCULOUS BACTERIAL INFECTIONS

' # % 1

+ ! % &

+ ! % ' ! ! . / 0 72 3

# : + , #1 H

# " + , #1 H

&# E 4 2 #+ H

1# E & #1 H

2# & #1 H

0# " + +

TIME AT WHICH THE INFECTION OCCURRED :

" .3/ ( # #

< 1 6 4#2,H 8 @ & 6,2H 8

"A ) 6 2H 8

I 0 6 1# 4H 8 6 ++H 8

0 I 6,# 1H 8 @ 6 ++H 8

% 26&2#, H 8 @ & 60+H 8

61+H 8

; 6 1# 4H 8 @ 6 ++H 8

RISK FACTOR ANALYSIS FOR THE BACTERIAL COHORT:

% ! ' ! ! 3

? C 01# 4

$.' 2 &2#,

"!> 1 4#2,

' ! 1# 4

"> 1# 4

(47)

1, D

! & 6 +#& H 8

E $'' C 6 1#+0H 8

' 6&1#&,H 8

D K 1, 64#CH 8

+ ! ' ! ! 0 78 3

# : & ++

# " & ++

&# E + ,0#C

1# 1 &+#,0

2# E 1 &+#,0

0# " + +

IMAGING PATTERN

+ ! % + $ 6 3 +

+ $ 3

2#&4 + +

G , 2&#41 2 &4#10

& 1 &+#,0 2#&4

1 + + 0 10# 2

(48)

14 DIAGNOSTIC METHODOLOGY

) $:3 2

3$? $:3 2

3$? &

TIME OF OCCURRENCE

" 3

# %0 2#&4

# ,% 2#&4

&# & I 1 2#&4

1# ; , 2&#41

RISK FACTOR ANALYSIS

% ! ' ! ! 3 $

! $ 3

? , 2&#41 21#04H

$.' 2 &4#10 1+#0&H

"!> 1 &+#,0 +#& H

' ! 1 &+#,0 4#,2H

"> 2#&4 #2H

(49)

1C

' # % &

) &

DIAGNOSTIC METHODOLOGY

) +

3$? $:3 &

3$? &

CLINICAL PROFILE

+ ! % ' ! ! . /0 8 3

# : + +

# " + +

&# E + +

1# + +

2# E + +

0# " + +

,# > & ++

TIME OF OCCURRENCE

" 3

%0 + +

,% + +

& & I 1 00#00

1 ; &&#&&

(50)

2+

IMAGING

+ ! + $ 6 3 + !$ 3

+ + +

G + + +

& & ++ & ++

RISK FACTOR ANALYSIS

% ! ' ! ! 3

? 00#00

$.' 00#00

"> 00#00

' ! &&#&&

"!> &&#&&

(51)

2

' # 4

# ! $ #

) @A

) "

3$? @A

3$? 1

"'

CLINICAL PROFILE

+ ! % ' ! ! . /0 9 3

: 0 4+

" 2 0 #2

& E & &,#2+

1 E 1 2+

2 #2

0# " #2

(52)

2 TIME OF OCCURRENCE

" 3

%0 +

,% + +

& & I 1 1 2+

1 ; +

IMAGING

+ ! % + $ 6 : 3 + !$ 3

#2 #2

G #2 #2

& 0 ,2 0 ,2

RISK FACTOR ANALYSIS

! ' ! ! 3 $ ! $ 3

? 0 4+ 21#04H

$.' 2 0 #2 1+#0&H

"> + +#& H

"!> + 4#,2H

' ! #2 #2H

FUNGAL SPECIES IDENTIFIED:

! ' ! ! . / 3

! 2H

" 0 ,2H

(53)

2&

' #

' # % , K01 6 0H 8

+ ! % &

+ ! % ' ! ! 0 7; 3

: ,+#24H

" ,+#24H

& E 0 &2# CH

1 E , 1 # ,H

2 #,0H

0# " + +

(54)

21

TIME AT WHICH THE INFECTION OCCURRED

"

.3/

( # #

< & 6 ,#01H 8 3

: O

I 0 2 6 C#1 H 8 ' O 1

: O

0 I +

% & 6 ,#01H 8 ' O

: O

; 0 6&2# CH 8 3

' O

' O O

RISK FACTOR ANALYSIS FOR THE MIX INFECTIONS:

% ! ' ! ! 3 $ ! $ 3

? 4 1,#+2H 21#04H

$.' 4 1,#+2H 1+#0&H

"!> & ,#01H +#& H

' ! 1 &#2 H 4#,2H

"> & ,#01H #2H

(55)

22 0,

+++ ++0 #

# &#C,H #

' , 2+

& N 4#4 # ' 1CK01 6,0#20H 8#

: 04#,2H

0+#C& H #

' 2#0&H 12#&

H # E 4#,2 H #

# ,K01 6 0#20H 8 # '

#

(56)

20

' "@ = 60,# 4H 8

# '

# "-

2#0 H # "-

# -

E). # 3 E). # '

6 8 #

' F C2#&H

#

! = 6,0#20H 8 6

O B O 8 # '

#

' =

# '

# B

# # I 1 #

(57)

2,

GRAFT FUNCTION AT BASE LINE AND DURING INFECTION

$

# ,#4 H ?.' #

1 # 4H #

TIME AT WHICH THE INFECTION OCCURRED

' .

# # B#

8# +%1

#

8# % 0

#

&8# 0%

18# % 1

#

(58)

24

OUR Cs A WITHDRAWAL PROTOCOL

+ ) )< $ "

% 1 K #2 K &+ K

% 1 K #2 K &+ K

+ #, K #2 K &+ K

1 #& K #2 K &+ K

4 ) #2 K &+ K

#2 K 2 K

0 #2 K + K

+ #2 K 2 K

1 #2 K + K

$ 1 #2 K + K

$ 1#+0H 4# H ,#4 H 2H 2H

< 0 0

; #

! 0

# ? 0

(59)

2C

#

' #&+# '

" $ #

MICROBIOLOGY WITH RESPECT TO POST TRANSPLANT DURATION

= 7 $&

@ 622#22H 8

6 # H 8# ' 6

D ! 8# '

#

#

>: 1 $ &

' 6&4#4H 8 5

# : 6 H 8 "

#

(60)

0+

1 $ 7 ? &

$ 61+H 8 #

5 #

7: >

'

" !

' " $

# " $

4

@ >

'

5 2

F

#

(61)

0 Bacterial

Infections Klebsiella, pseudomonas

M. Tuberculosis

Fungal infections Mucor, candida Fungal infections

candida Atypical mycobacteria

Polymicrobial infections

<1 month 2- 6 months 7- 12 months 1- 2ndyear

' ' ' #

(62)

0

RISK FACTORS FOR DEVELOPING POST TRANSPLANT PULMONARY INFECTION

' = 6$.'8

"!> ">

# '

# 1.LEUCOPENIA

?

B

# ) "!>

#

621#04H 8

# ! # 3

# 2. ART:

$.' =# ! 2 K

@ K & # J

# )

(63)

0&

# 1+# 0& H

# 3. CMV

' "!>

# '

"!> =

$.' # ! "!>

#

+#& H #

4. HCV

"> #

">

# '

# '

% ">

# #2 H = #

(64)

01 5. PTDM

' ! ; 0 K

; 4+ K

#

# 4#,2H

#

SENSITIVITY OF SPUTUM STAINING VS. CULTURE/

SENSITIVITY

' 6- @A $:3

8 1#1&H # 2#0 H

#

SENSITIVITY OF SPUTUM ANALYSIS VS BAL

) 6 8

3 $? 6&2#C&H ++H 8 L < +#++ #PM 1#21 C2H " 01H 61C I ,C8Q 3 $?

# SENSITIVITY OF IMAGING MODALITIES

"' 7%

6,C#0CH #4 #,0H 8 # 7%

+#& H "' 6 ,# 1H 8

(65)

02

3 1K01

6 #4,H 8 #

:

, #1 H # #1 H #

6&2#, H 8 6 4#2,H 8#

5 6,# 1 H 8 , %

# MICROBIOLOGY OF INFECTIONS 7 = 7 $&

@ 6,2H 8

# '

6 D 8#

(66)

00

> 7 > &

@ 60+H 8

61+H 8#

ANALYZING THE RISK FACTORS

? $.' "!> ' ! ">

01# 4H &2#, H 4#2,H 1# 4H 1# 4H

(67)

0,

2#,H + H 1 #

64#CH 8

D

! & 6 +#& H 8

E $'' C 6 1#+0H 8

' 6&1#&,H 8

:

#

: 5

# " ,0#C H #

&+#,0H # ' #

' 7% = 62&#41H 8#F

&+#,0H # 7% 2#&4H #"'

#

(68)

04

) $:3 &4#10H # '

0 #2 H 5 3 $? #

& #+,H 3 $? !

5

# '

#

5 . * #

2#&4H 0 0

#

? 2&#41H $.' &4#10H ">

2#1H # "!> 6&+#,0H 8 ' ! 6&+#,0H 8

# TREATMENT

$ $'' 6 . E

B 8 4 #

(69)

0C

$ ! 1#0CH #

$

# ' K # '

#

" 7 "' & #

)

3$? $:3 #

A C+ '!

& # '

!#'3 F

F #

? $.' # ' ! "!>

"> #

$

6A " % B $ 8#

(70)

,+

' 4 #2H

: 64+H 8 "

0 #2H #

#

4+H # A # A

"' #

3$? 62+H 8#) @A

# '

"' 6! 8#

! 62+H 8

# #

+ H # # 0 #

3 ,

#

(71)

,

? 4+H # $.'

0 #2H # ' 5

#

"!> "> + H ' !

#2H #" 6,2H 8

! 6 2H 8#

$ #A 6!

8

# 6 +H 8 # 3

# A ! #

(72)

,

0#20H #

:

,+#24H # " &2# CH #

#,0H

5 6 C#1 H 8

0

# $

, # 3 ,#01H

#

PERIOD OF OCCURRENCE 1. = 7 $ &

O #

> >: 1 $ &

!#'3

1 # O

(73)

,&

8 7 > &

!#'3 # :

# 2 )% >

!#'3

#

? $.' "!> ' ! ">

1,#+2H 1,#+2H ,#01H &#2 H ,#01H #

#

(74)

,1

=

&#C,H

# A

#

@

#

! 0

#

) " $

'

" ##

!

#

' 5 1H

3$? ++H

7

! 5 3$?

"

#

0 #

(75)

,2

# 9# " #% .

%@ %

#9#! %2

# 9 # $# : . # # . 6 CC48% A

% # E # 9#! F&&4# 1

&# - #'#9 # 6 CC08%$ '

# ' F0 F0

1# > ) = # 6 CC08%'

%

' 0 F F % 2

2# : 9#$# . .# # 6 CC48#

#

& E 69#$# #8 # 2& ! - %

R #

0# 9#!#' 9# # R 9#$#6 C4&8#.

#? CC#

(76)

,0

,# $ .#"# 9 #"# ! $#- 6 CC&8#

# " # # # 0 2+2#

4# ! 9# )# ) J # ) J # 9# 6 C408#

A #

' 1 2 4#

C# .#!#3 )#?# 9#!# ! #9#6 C448.

B

# ' 1, 224#

+# R R #?# " J # !#9# 6 C408# "

#S #9#!#2C 1 #

# 3 # # ! # " 9# ?# 6 C408# G

$ )# $ # . #. # # && 2 2#

# J $# E# ! .#!# - ?# 9# !#

6 CC 8 # $

#

&# @ !# - !# 3##6 CC48# ?

(77)

,,

. 6!#E #8 #&# " G

" #

1# 9#!#6 CC 8# # # A

G A

2# R 9#$# 9#!# " J # # 6 C418

D

# 9#

" # # &, &C+

0# ! E# # ) 9# A # ! ? '# "# 6 CC+8#

# . ,2 ,&&#

,# : #E# ? .#9# 6 C448# '

A 3

# " ) # " # # $ # 1 ,1C

4# #J # 6 C418 $

# $ # 9#! # ,0 2+ #

C# $ # 3 # E# 6 CC 8# $ #

$ # ! +C% 42

(78)

,4

+# #J # 6 CC08# '

# " # # # & 1,

# 3 $ " # ' " #

$ # > 2

9 ++ #

# . . ' A ' .

" $ ' ' " #

& # R CC1#0 1 ,+2

&# . . " A .

' #@ # # CC& 11 & %&&0

1# : 9$ $

' # # $ CC2DC +&2%11

2# ) @ $J # :

# # $ CC2F

C +12%,1

0# # #@# : . : #)#

. ' . D $

#

! 6 3 8 C4 D0 &0+

(79)

,C

,# # " @ : E # ?

5

# ' # CCCD& +

4# ! # ?

? C4 # 2 2#

C# 9 . @ ?

' . # .

# ? # CC # 20,%C1#

&+# - '# 9 #$

# ' CC0F0 0

& # @ #>#!# #

9 ! . A ++1#

& # ' # E

) 9 @ ' ++ D & 618 112% 12+

(80)

!

" # $ $

% & ' (

(

) ( * ' &

+ ,- . / / 0 0 . 1 1 1 ,0 230 1 . . 1 . 1 1 1 1 1 1 1 . *

4/ . / 5 0 6 . 1 1 1 24 75 5 2 . 1 1 . 1 . 1 1 1 . 1 .

$ ,6 / 5 0 / . 1 1 1 2 0 0 1 1 1 1 . * 1 1 1 1 1 1 1 )

+ ) 72 8 1 / 5 3/ . 1 1 1 2 35 1 1 1 1 1 1 1 1 1 1 1 1 1 )

9 . -4 / 2 0 0 . . 1 1 - 0 0 1 1 1 1 1 . 1 1 . 1 1 1 1 1 *

" * -4 / - 0 0 . . 1 . 70 7-- 1 . . 1 1 . 1 1 1 1 : . . *

1 76 / / 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 !)

+ 7/ 8 / / 35 . . 1 1 -7 240 1 . 1 1 1 . 1 1 . 1 1 1 1 1 *

8 ,, / 7 0 0 . . 1 1 70 -73 2 . 1 . . . * 1 1 ( 1 1 1 1

% ) . ,, 8 / 7 0 0 . . 1 1 2 0 0 1 1 1 1 1 1 1 1 & 1 1 1 1 *

9 ; -/ 8 1 / 5 -/ , . 1 1 1 2 -75 1 . 1 1 1 . 1 1 1 ( 1 1 1 1 *

* * -5 / - 22/ 1 . 1 1 - 225 1 . 1 1 1 . 1 1 1 1 ( . 1

) -7 / 4 0 0 . . 1 1 3 ,,7 2 . . . . . 1 1 . 1 1 1 1 1 *

-7 / - 35 . . 1 1 -7 3/ 1 1 1 1 1 1 1 1 1 1 1 1 1 1 *

,2 / - 0 0 . . 1 1 6- 20 7 1 1 1 1 . . 1 1 . 1 1 1 1 1 *

$ 8 . 1 ) ,2 / , 0 0 . . 1 1 ,- 247 1 1 . . . . 1 1 1 1

:

1 .

73 8 / 5 0 5 . . 1 1 2 0 0 1 1 . 1 1 . 1 1 1 ( 1 1 1 1 *

$ 11 -- 8 1 / 2 0 0 1 . 1 1 5 / 2/ 5 1 1 1 1 1 . 1 1 1 ( 1 1 1 1 *

,6 8 1. / - 0 0 . . 1 1 2, 2-, 1 1 1 1 1 . 1 1 1 1 1 1 1 1 )

% 7/ 8 1 / / 35 . . 1 1 7 2/ 4 1 1 1 1 1 . 1 1 1 1 1 1 1 1 )

< 8 26 / , 0 0 . . 1 1 70 75 5 1 1 1 1 1 1 1 1 1 1 1 1 1 1 )

1) -/ / 7 2-4 . . 1 1 - 27/ 1 1 1 1 1 1 1 1 1 1 1 1 1 1 )

# ) 75 / / 0 0 1 1 1 1 1 . 1 1 1 1 1 1 1 1 1 1 1 )

7- / 2 2/ / . . 1 1 27 -23 1 1 1 1 . 1 1 1 ( 1 1 1 * 1 *

(81)

!

" # $ $

% & ' (

(

) ( * ' &

) -4 / 2 0 0 . . 1 1 75 20 7 1 1 1 1 1 1 1 1 1 1 1 1 1 )

-6 / 7 3/ . . 1 1 6 244 1 1 1 1 1 1 1 1 1 ( ( 1 1 * 1 *

1 ,0 * / 7 20 7 . . 1 1 24 2/ 4 . . 1 1 . . 1 1 1 1 1 1 1 1 *

. -2 8 1 / 2 0 0 1 1 1 1 1 . 1 1 1 1 1 1 1 1 1 1 1 )

" 1 ,4 8 / 7 0 0 1 1 1 1 20 ,/ 6 2 . 1 1 1 . 1 1 1 1 1 1 1 * 1 *

= * ) * ,6 / , 0 0 . . 1 1 , 2-, 2 . 1 1 1 . * 1 1 1 1 1 1 1 )

$ 1 ,, / 2 0 0 . . 1 1 25 2/ 4 1 1 . 1 1 . 1 1 1 1 1 1 1 )

1 ) -- / , 0 0 . . 1 1 3 245 1 . 1 1 . . 1 1 1 1 1 1 1 1 )

* ,4 / - 2/ 4 . . 1 1 2, 24/ 1 . 1 1 1 . 1 1 1 1 1 1 1

-/ / 4 0 0 . . 1 1 24 2/ 4 1 1 1 1 . . 1 1 1 ( 1 1 1 1 )

7, / - 0 0 . . 1 1 2 2/ 4 1 1 1 1 . 1 1 1 1 1 1 1 1 *

$ 23 / - 3/ . . 1 1 ,5 ,4- 1 . 1 1 1 . >

* 1 1 1 1 1 1 1 )

) -, / 2 0 0 . . . 1 ,5 2-5 1 1 1 1 1 . 1 1 1 1 1 1 1 1 )

-, / 2 0 0 . . . . 5 / 277 1 1 1 1 1 . 1 1 1 ( 1 1 . *

) -5 / 5 0 0 . . . 1 2 0 0 1 1 1 1 1 . 1 1 1 1 1 1 1 1 *

. -4 / 2 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1

. 8 -0 ./ - 0 0 . 1 . 1 2 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1

* -- * / - 0 0 . . . . -7 2/ 4 2 . 1 1 1 1 1 1 1 1 1 1 1 1 )

1 ,- / , 0 0 . . . 1 - 2/ 4 1 1 1 1 1 1 1 1 1 1 1 1 1 1 *

. ,/ 8 '/ 2 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 *

4/ 8 1'/ 4 2-, . 1 1 1 26 27- 1 1 . 1 1 1 1 1 1 1 1 1 1 1 *

1 * -6 .'/ 4 0 0 . . 1 1 2, 2-, 1 1 . 1 . 1 1 1 1 1 * 1 . * 1

% ) -- '/ , 2-, . . . 1 -6 --0 2 . 1 1 1 . 1 1 1 1 * 1 1 * 1

) -3 .'/ - 0 0 . . . 1 2 -/ 4 1 . 1 1 1 1 1 1 1 1 1 1 1

(82)

&

!

" # $ $

% & ' (

(

) ( * ' &

+ 1 ) 7, / 4 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 *

% ,5 8 / 5 0 0 1 1 1 1 2/ -,0 2 . . . . . 1 1 1 1 1 1 1 * 1 *

+ 1 -7 / , 0 0 1 1 1 1 1 1 . 1 1 1 1 1 1 1 1 1

" ) -/ / 2 0 0 . . . 1 - 2-, 1 1 . 1 1 1 1 1 1 1 1 1 1

" 1 ) -4 / 2 0 0 . . . 1 5 / 24, 1 1 1 1 1 * 1 1 1 1 1 1

" -3 / / 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 *

,/ * / 2 0 0 1 1 1 . 70 --2 2 . 1 . . . 1 1 1 1 1 1 1 1

1) -5 / 7 0 0 . . . . ,/ 35 2 . 1 1 1 1 1 1 1 . . .

) -, 8 / 2 35 . . . 1 2- 234 2 . 1 . . . 1 1 1 1 1 1 1 1

8 ,/ / , 0 0 . . 1 1 24 1 1 . 1 1 1 1 1 ( * 1 1 *

) 1 -4 / - 0 0 1 1 1 1 24 1 . . 1 1 . 1 1 1 1 1 1 . *

+ . -0 / , 0 0 1 1 1 1 7 1 . 1 1 1 1 1 1 1 * 1 .

) 1 ,0 . - 0 0 1 1 1 1 24 1 1 . 1 1 1 1 1 . 1 1 1 1 1 *

. -4 8 / , 0 0 1 1 1 1 ,0 1 1 1 . . * 1 1 ( 1 1 1 1 *

$ . . ,- / , 0 0 1 1 1 1 4 1 . 1 1 1 1 1 1 ( 1 1 1 1 *

# ,, / 7 0 0 1 1 1 1 2, 1 1 1 1 . 1 1 1 1 1 1 1 1

References

Related documents

There may be a male bias in the selection of cases in the study The study did not differentiate between relapse relapse due to reinfection from relapse due to

I solemnly declare that the dissertation titled “A STUDY ON THE CORRELATION BETWEEN SPUTUM SMEAR STATUS AND CD4 COUNT IN CASES OF PULMONARY TUBERCULOSIS WITH HIV

Till date only one study on pulmonary hypertension in post renal transplantation with Doppler echocardiography was done by Issa et al reported pulmonary

Number of related donors : 26 Shortest post transplant period among related donors : 1 year Longest post transplant period among related donors : 27 years Mean

To asses the incidence of anemia in post renal transplant patients with successful engraftment, and evaluate the possible factors contributing to an inappropriate

In the literature, the risk factors for developing fungal infection in the post renal transplant setting were the following like deceased donor and retransplantation,

The only episode of nocardial infection in this study presented in 14 th month post transplant surgery and this patient was suffering from hepatitis, a

From our study HIV positive people with pulmonary tuberculosis may have a higher frequency of negative sputum smears in advanced state of HIV infection.. So confirming